.AstraZeneca executives mention they are "not anxious" that the failure of tozorakimab in a period 2...
.Welcome to this week's Chutes & Ladders, our roundup of substantial leadership hirings, firings ...
.After revealing plans to hit the U.S. public markets less than a month ago, Zenas Biopharma and als...
.Psyence Biomedical is actually paying $500,000 in allotments to obtain fellow psilocybin-based biot...
.5 months after endorsing Power Therapies' Pivya as the 1st new procedure for uncomplicated urinary ...
.Eli Lilly has sprung right into an AI-enabled drug discovery deal, partnering with RNA expert Hered...
.Lykos chief executive officer and also owner Amy Emerson is actually stepping down, with main opera...
.Novartis levels a brand-new frontier in its cooperation along with Voyager Rehabs, paying $15 thous...
.On the heels of an FDA being rejected for its chief rival Novo Nordisk, Eli Lilly is actually pulli...
.Merely a couple of months after application the initial patient in a period 2 trial for freshly det...